Long-Term Clinical and Molecular Remission After Allogeneic Stem Cell Transplantation (SCT) in Patients With Poor Prognosis Non-Hodgkin's Lymphoma

Leukemia - United Kingdom
doi 10.1038/sj.leu.2402053